<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">04433</article-id><article-id pub-id-type="doi">10.7554/eLife.04433</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-18247"><name><surname>Baptista</surname><given-names>Antonio P</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18248"><name><surname>Roozendaal</surname><given-names>Ramon</given-names></name><aff><addr-line><named-content content-type="department">Crucell Vaccine Institute</named-content></addr-line>, <institution>Janssen Center of Excellence for Immunoprophylaxis</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18249"><name><surname>Reijmers</surname><given-names>Rogier M</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18250"><name><surname>Koning</surname><given-names>Jasper J</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18251"><name><surname>Unger</surname><given-names>Wendy W</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18252"><name><surname>Greuter</surname><given-names>Mascha</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18253"><name><surname>Keuning</surname><given-names>Eelco D</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18254"><name><surname>Molenaar</surname><given-names>Rosalie</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18255"><name><surname>Goverse</surname><given-names>Gera</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18256"><name><surname>Sneeboer</surname><given-names>Marlous M S</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12609"><name><surname>den Haan</surname><given-names>Joke M M</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18257"><name><surname>Boes</surname><given-names>Marianne</given-names></name><aff><addr-line><named-content content-type="department">Department of Pediatric Immunology, Laboratory of Translational Immunology</named-content></addr-line>, <institution>University Medical Center Utrecht</institution>, <addr-line><named-content content-type="city">Utrecht</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-17703"><name><surname>Mebius</surname><given-names>Reina E</given-names></name><aff><addr-line><named-content content-type="department">Department of Molecular Cell Biology and Immunology</named-content></addr-line>, <institution>Vrije Universiteit Medical Center</institution>, <addr-line><named-content content-type="city">Amsterdam</named-content></addr-line>, <country>Netherlands</country><email>r.mebius@vumc.nl</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-7659"><name><surname>Unanue</surname><given-names>Emil R</given-names></name><role>Reviewing editor</role><aff><institution>Washington University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>11</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e04433</elocation-id><supplementary-material><ext-link xlink:href="elife-04433-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>21</day><month>08</month><year>2014</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>Copyright Â© 2014, Baptista et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Baptista et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Non-hematopoietic lymph node stromal cells shape immunity by inducing MHC-I-dependent deletion of self-reactive CD8<sup>+</sup> T cells and MHC-II-dependent anergy of CD4<sup>+</sup> T cells. Here, we show that MHC-II expression on lymph node stromal cells is additionally required for homeostatic maintenance of regulatory T cells (Tregs) and maintenance of immune quiescence. In the absence of MHC-II expression in lymph node transplants, i.e. on lymph node stromal cells, CD4<sup>+</sup> as well as CD8<sup>+</sup> T cells became activated, ultimately resulting in transplant rejection. MHC-II self-antigen presentation by lymph node stromal cells allowed the non-proliferative maintenance of antigen-specific Tregs and constrained antigen-specific immunity. Altogether, our results reveal a novel mechanism by which lymph node stromal cells regulate peripheral immunity.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were reviewed and approved by the Vrije University Scientific and Ethics Committees (protocols MCB09-35, MCB10-01 and MCB13-06). All surgery was performed under xylazine and ketamine anesthesia.</p></fn></fn-group></back></article>